QWM
AZN icon

Quaker Wealth Management’s AstraZeneca AZN Stock Holding History

Quaker Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-406
Closed -$59.7K – 946
2025
Q1 		$59.7K Buy
+406
New +$58.7K 0.02% 136

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Quaker Wealth Management's AZN Position: Q2 2026 in Review

Quaker Wealth Management held its AstraZeneca (AZN) position steady in Q2 2026 at 408 shares worth $77.4K. The position accounts for 0.02% of the portfolio, ranked #133.

Quaker Wealth Management first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $80.5K in Q1 2026. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Quaker Wealth Management held 408 shares of AstraZeneca worth $77.4K as of Q2 2026.
  • Quaker Wealth Management left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.02% of Quaker Wealth Management's portfolio in Q2 2026, its #133 holding.
  • Quaker Wealth Management first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
  • Quaker Wealth Management's AstraZeneca position peaked at $80.5K in Q1 2026.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.